Search results for "Gout"
MKSAP Quiz: 4-week history of dyspnea on exertion
A 54-year-old woman is evaluated for a 4-week history of dyspnea on exertion, malaise, fatigue, and anorexia. History is significant for hypertension, gout, and osteoarthritis. Following a physical exam, lab studies, and chest radiograph, what is the most likely diagnosis?
https://immattersacp.org/weekly/archives/2020/10/27/3.htm
27 Oct 2020
Inappropriate medications prescribed in some Medicare patients with CKD, study finds
Over a third of patients with chronic kidney disease (CKD) enrolled in a Medicare plan's Medication Therapy Management program in 2018 received a prescription for at least one potentially inappropriate medication.
https://immattersacp.org/weekly/archives/2021/02/02/5.htm
2 Feb 2021
MKSAP Quiz: 3-day history of left knee pain, swelling
A 43-year-old woman is evaluated for a 3-day history of left knee pain and swelling. Similar episodes have occurred in either knee as well as the left wrist during the past 2 years. Following a physical exam, radiographs, and joint aspiration of the left knee, what laboratory study will most likely identify the cause of this patient's symptoms?
https://immattersacp.org/weekly/archives/2021/03/16/3.htm
16 Mar 2021
Allopurinol not associated with increased mortality in patients with CKD, gout
The findings of a database analysis from the United Kingdom provide reassurance that a treat-to-target strategy has no apparent harmful effect on mortality in patients with gout and chronic kidney disease (CKD).
https://immattersacp.org/weekly/archives/2022/01/25/2.htm
25 Jan 2022
Gout flares may precede cardiovascular events
A retrospective study found that gout patients who experienced an acute myocardial infarction or stroke had significantly higher odds of a recent gout flare in the preceding four months than those who did not.
https://immattersacp.org/weekly/archives/2022/08/09/1.htm
9 Aug 2022
Hydrochlorothiazide no better than placebo for preventing kidney stone recurrence
A randomized, double-blind, placebo-controlled trial in Switzerland found that patients with a history of recurring kidney stones were no less likely to experience symptomatic or radiologic recurrence with hydrochlorothiazide versus placebo.
https://immattersacp.org/weekly/archives/2023/03/07/1.htm
7 Mar 2023
Separate industry-funded studies find benefit to bempedoic acid as preventive medication, CRP as biomarker
Bempedoic acid reduced cardiovascular (CV) events among patients unwilling or unable to take statins, a trial found, while a review showed that high-sensitivity C-reactive protein (CRP) was a stronger predictor for risk of future CV events and death than cholesterol in patients on statins.
https://immattersacp.org/weekly/archives/2023/03/14/4.htm
14 Mar 2023
Colchicine linked to lower incidence of total knee, hip replacements in patients with chronic coronary artery disease
Compared to placebo, colchicine (0.5 mg once daily) was associated with a 31% lower incidence of total knee replacements and total hip replacements, an exploratory analysis of a randomized controlled trial found.
https://immattersacp.org/weekly/archives/2023/05/30/1.htm
30 May 2023
SGLT-2 inhibitors reduced gout flares in patients with diabetes, gout
New users of sodium-glucose cotransporter-2 (SGLT-2) inhibitors had about half the risk of an ED visit or hospitalization for a gout flare as matched patients taking dipeptidyl peptidase-4 inhibitors, a cohort analysis found.
https://immattersacp.org/weekly/archives/2023/07/25/1.htm
25 Jul 2023
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/09/spotlight.htm
1 Sep 2023